| Net Cash Provided by (Used in) Operating Activities |
$1,025,000 |
USD |
-74% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$730,000 |
USD |
-106% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$276,000 |
USD |
59% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
37,500,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
18,596,301 |
shares |
0.06% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$16,000 |
USD |
-99% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$144,000 |
USD |
-8.3% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$7,896,000 |
USD |
-16% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$171,000 |
USD |
21% |
Q4 2024 |
FY 2024 |
| Depreciation |
$1,800,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$487,000 |
USD |
-44% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$828,000 |
USD |
-81% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$195,000 |
USD |
34% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$121,869,000 |
USD |
4.9% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$70,000 |
USD |
-42% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$66,000 |
USD |
214% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$89,000 |
USD |
-29% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.1 |
pure |
69% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$24,000 |
USD |
380% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$103,644,000 |
USD |
0.5% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$1,867,000 |
USD |
3.7% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$5,429,000 |
USD |
9.3% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$0 |
USD |
-100% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |